{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"atlas","mode":"comparison","updatedThrough":"2026-08-15","guardrail":"A bilateral atlas route preserves a sequence of declared edges for navigation and audit. A direct edge, common neighbor, or multi-hop path does not make the endpoints equivalent, establish ownership or control, assign liability, define an antitrust market, make unlike measures comparable, or show causation.","filters":{"layer":"research","layerMatched":true,"left":"topic:methods-public-data","leftMatched":true,"right":"issue:health-care-intermediaries","rightMatched":true,"view":"paths"},"summary":{"nodeCount":5478,"edgeCount":19193,"sourceCount":0,"profileCount":5433,"nodeKindCount":13,"layerCount":4,"directEdgeCount":1,"disconnected":false,"eligibleEdgeCount":547,"ledgerEdgeCount":1,"leftNeighborCount":5,"pathLimitReached":false,"rightNeighborCount":4,"sharedNeighborCount":0,"shortestHopCount":1,"shortestPathCount":1},"endpoints":{"left":{"id":"topic:methods-public-data","kind":"topic","label":"Methods and Public Data","shortLabel":"Methods and Public Data","description":"What can current public records establish, where do measurement boundaries stop, and which disclosures would make antitrust research more accountable?","href":"/research/topics/methods-public-data","metricLabel":"Publication memberships","metricValue":"3","detail":"AR-T07 / 2 issue programs / 5 evidence lanes","status":"institutional research topic","year":2026,"color":"#ea580c","searchText":"ar-t07 methods and public data methods what can current public records establish, where do measurement boundaries stop, and which disclosures would make antitrust research more accountable? document definitions, denominators, source construction, release clocks, reproducibility paths, and evidence gaps as first-class research outputs. a documented data gap is not evidence of competition or harm. screening thresholds are not legal conclusions, and reproducibility does not make unlike measures comparable. stable identifiers, machine-readable firm shares and ownership, local boundaries, historical revisions, disclosure status, methods documentation, and durable public apis. data publishers, analysts, students, reporters, agencies, and legislators ar-mm-2026-01 how hhi helps explain market concentration ar-dn-2026-01 where public market-share data runs out ar-dn-2026-02 housing competition needs local ownership data","connectionCount":5},"right":{"id":"issue:health-care-intermediaries","kind":"issue","label":"Health care intermediaries","shortLabel":"Health intermediaries","description":"How do insurer structure, PBM contracting, rebate, formulary, network, and organizational relationships affect competition and patient access across separately measured health-care systems?","href":"/issues/health-care-intermediaries","metricLabel":"Bounded markets","metricValue":"2","detail":"2 separately defined markets / editorial research program","status":"issue program","year":2024,"color":"#c026d3","searchText":"health care intermediaries health intermediaries insurance, pbm contracting, access, and public-data gaps the program connects the 2024 kff state individual-insurance concentration cross-section to separately bounded public pbm facts, named official records, source limits, and evidence requests without treating payer and prescription-intermediary systems as one market. how do insurer structure, pbm contracting, rebate, formulary, network, and organizational relationships affect competition and patient access across separately measured health-care systems? which comparable state insurer enrollment, claims, prescription, rebate, and network records can establish firm-level structure under stable ownership identifiers? how do plan entry, insurer structure, contracting, formulary, and network practices differ across payer, pharmacy, patient, and geographic segments? which ownership and control relationships are supported by exact filings rather than name similarity or market context? u.s. pharmacy benefit management pbms health care u.s. aca individual health insurance individual insurance health insurance","connectionCount":4}},"shortestPaths":[{"id":"path:topic-issue:methods-public-data:health-care-intermediaries","edges":[{"id":"topic-issue:methods-public-data:health-care-intermediaries","type":"topic_issue","layer":"research","from":"topic:methods-public-data","to":"issue:health-care-intermediaries","label":"Declared issue-program membership","detail":"Health care intermediaries is explicitly included in the Methods and Public Data institutional research contract.","evidenceLabel":"Research topic issue contract","sourceId":null,"sourceUrl":null,"confidenceLevel":"bounded","guardrail":"A topic-to-issue link records one declared institutional membership. It does not merge the issue program's markets, establish harm, rank importance, or imply a shared method or finding."}],"hopCount":1,"nodes":[{"id":"topic:methods-public-data","kind":"topic","label":"Methods and Public Data","shortLabel":"Methods and Public Data","description":"What can current public records establish, where do measurement boundaries stop, and which disclosures would make antitrust research more accountable?","href":"/research/topics/methods-public-data","metricLabel":"Publication memberships","metricValue":"3","detail":"AR-T07 / 2 issue programs / 5 evidence lanes","status":"institutional research topic","year":2026,"color":"#ea580c","searchText":"ar-t07 methods and public data methods what can current public records establish, where do measurement boundaries stop, and which disclosures would make antitrust research more accountable? document definitions, denominators, source construction, release clocks, reproducibility paths, and evidence gaps as first-class research outputs. a documented data gap is not evidence of competition or harm. screening thresholds are not legal conclusions, and reproducibility does not make unlike measures comparable. stable identifiers, machine-readable firm shares and ownership, local boundaries, historical revisions, disclosure status, methods documentation, and durable public apis. data publishers, analysts, students, reporters, agencies, and legislators ar-mm-2026-01 how hhi helps explain market concentration ar-dn-2026-01 where public market-share data runs out ar-dn-2026-02 housing competition needs local ownership data","connectionCount":5},{"id":"issue:health-care-intermediaries","kind":"issue","label":"Health care intermediaries","shortLabel":"Health intermediaries","description":"How do insurer structure, PBM contracting, rebate, formulary, network, and organizational relationships affect competition and patient access across separately measured health-care systems?","href":"/issues/health-care-intermediaries","metricLabel":"Bounded markets","metricValue":"2","detail":"2 separately defined markets / editorial research program","status":"issue program","year":2024,"color":"#c026d3","searchText":"health care intermediaries health intermediaries insurance, pbm contracting, access, and public-data gaps the program connects the 2024 kff state individual-insurance concentration cross-section to separately bounded public pbm facts, named official records, source limits, and evidence requests without treating payer and prescription-intermediary systems as one market. how do insurer structure, pbm contracting, rebate, formulary, network, and organizational relationships affect competition and patient access across separately measured health-care systems? which comparable state insurer enrollment, claims, prescription, rebate, and network records can establish firm-level structure under stable ownership identifiers? how do plan entry, insurer structure, contracting, formulary, and network practices differ across payer, pharmacy, patient, and geographic segments? which ownership and control relationships are supported by exact filings rather than name similarity or market context? u.s. pharmacy benefit management pbms health care u.s. aca individual health insurance individual insurance health insurance","connectionCount":4}]}],"sharedNeighbors":[],"nodes":[{"id":"issue:health-care-intermediaries","kind":"issue","label":"Health care intermediaries","shortLabel":"Health intermediaries","description":"How do insurer structure, PBM contracting, rebate, formulary, network, and organizational relationships affect competition and patient access across separately measured health-care systems?","href":"/issues/health-care-intermediaries","metricLabel":"Bounded markets","metricValue":"2","detail":"2 separately defined markets / editorial research program","status":"issue program","year":2024,"color":"#c026d3","searchText":"health care intermediaries health intermediaries insurance, pbm contracting, access, and public-data gaps the program connects the 2024 kff state individual-insurance concentration cross-section to separately bounded public pbm facts, named official records, source limits, and evidence requests without treating payer and prescription-intermediary systems as one market. how do insurer structure, pbm contracting, rebate, formulary, network, and organizational relationships affect competition and patient access across separately measured health-care systems? which comparable state insurer enrollment, claims, prescription, rebate, and network records can establish firm-level structure under stable ownership identifiers? how do plan entry, insurer structure, contracting, formulary, and network practices differ across payer, pharmacy, patient, and geographic segments? which ownership and control relationships are supported by exact filings rather than name similarity or market context? u.s. pharmacy benefit management pbms health care u.s. aca individual health insurance individual insurance health insurance","connectionCount":4},{"id":"topic:methods-public-data","kind":"topic","label":"Methods and Public Data","shortLabel":"Methods and Public Data","description":"What can current public records establish, where do measurement boundaries stop, and which disclosures would make antitrust research more accountable?","href":"/research/topics/methods-public-data","metricLabel":"Publication memberships","metricValue":"3","detail":"AR-T07 / 2 issue programs / 5 evidence lanes","status":"institutional research topic","year":2026,"color":"#ea580c","searchText":"ar-t07 methods and public data methods what can current public records establish, where do measurement boundaries stop, and which disclosures would make antitrust research more accountable? document definitions, denominators, source construction, release clocks, reproducibility paths, and evidence gaps as first-class research outputs. a documented data gap is not evidence of competition or harm. screening thresholds are not legal conclusions, and reproducibility does not make unlike measures comparable. stable identifiers, machine-readable firm shares and ownership, local boundaries, historical revisions, disclosure status, methods documentation, and durable public apis. data publishers, analysts, students, reporters, agencies, and legislators ar-mm-2026-01 how hhi helps explain market concentration ar-dn-2026-01 where public market-share data runs out ar-dn-2026-02 housing competition needs local ownership data","connectionCount":5}],"rows":[{"id":"topic-issue:methods-public-data:health-care-intermediaries","layer":"research","relationshipType":"topic_issue","relationshipLabel":"Declared issue-program membership","fromId":"topic:methods-public-data","fromKind":"topic","fromLabel":"Methods and Public Data","fromHref":"/research/topics/methods-public-data","toId":"issue:health-care-intermediaries","toKind":"issue","toLabel":"Health care intermediaries","toHref":"/issues/health-care-intermediaries","evidenceLabel":"Research topic issue contract","evidenceDetail":"Health care intermediaries is explicitly included in the Methods and Public Data institutional research contract.","sourceId":null,"sourceUrl":null,"confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A topic-to-issue link records one declared institutional membership. It does not merge the issue program's markets, establish harm, rank importance, or imply a shared method or finding."}]}